Global mRNA Drug Supply, Demand and Key Producers, 2023-2029

June 2023 | 101 pages | ID: G0040EB5D632EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global mRNA Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.

This report studies the global mRNA Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for mRNA Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global mRNA Drug total production and demand, 2018-2029, (K Units)

Global mRNA Drug total production value, 2018-2029, (USD Million)

Global mRNA Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global mRNA Drug consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: mRNA Drug domestic production, consumption, key domestic manufacturers and share

Global mRNA Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global mRNA Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global mRNA Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global mRNA Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca and Janssen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Drug market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global mRNA Drug Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global mRNA Drug Market, Segmentation by Type
  • Preventive Vaccines
  • Therapeutic Vaccine
  • Therapeutic Drugs
Global mRNA Drug Market, Segmentation by Application
  • Hospital
  • Clinic
Companies Profiled:
  • Moderna
  • Pfizer
  • Zydus Cadila
  • Fosun Pharma
  • CureVAC
  • Sri Lankan Microorganisms
  • BioNtech
  • AstraZeneca
  • Janssen
Key Questions Answered

1. How big is the global mRNA Drug market?

2. What is the demand of the global mRNA Drug market?

3. What is the year over year growth of the global mRNA Drug market?

4. What is the production and production value of the global mRNA Drug market?

5. Who are the key producers in the global mRNA Drug market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 mRNA Drug Introduction
1.2 World mRNA Drug Supply & Forecast
  1.2.1 World mRNA Drug Production Value (2018 & 2022 & 2029)
  1.2.2 World mRNA Drug Production (2018-2029)
  1.2.3 World mRNA Drug Pricing Trends (2018-2029)
1.3 World mRNA Drug Production by Region (Based on Production Site)
  1.3.1 World mRNA Drug Production Value by Region (2018-2029)
  1.3.2 World mRNA Drug Production by Region (2018-2029)
  1.3.3 World mRNA Drug Average Price by Region (2018-2029)
  1.3.4 North America mRNA Drug Production (2018-2029)
  1.3.5 Europe mRNA Drug Production (2018-2029)
  1.3.6 China mRNA Drug Production (2018-2029)
  1.3.7 Japan mRNA Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 mRNA Drug Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 mRNA Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World mRNA Drug Demand (2018-2029)
2.2 World mRNA Drug Consumption by Region
  2.2.1 World mRNA Drug Consumption by Region (2018-2023)
  2.2.2 World mRNA Drug Consumption Forecast by Region (2024-2029)
2.3 United States mRNA Drug Consumption (2018-2029)
2.4 China mRNA Drug Consumption (2018-2029)
2.5 Europe mRNA Drug Consumption (2018-2029)
2.6 Japan mRNA Drug Consumption (2018-2029)
2.7 South Korea mRNA Drug Consumption (2018-2029)
2.8 ASEAN mRNA Drug Consumption (2018-2029)
2.9 India mRNA Drug Consumption (2018-2029)

3 WORLD MRNA DRUG MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World mRNA Drug Production Value by Manufacturer (2018-2023)
3.2 World mRNA Drug Production by Manufacturer (2018-2023)
3.3 World mRNA Drug Average Price by Manufacturer (2018-2023)
3.4 mRNA Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global mRNA Drug Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for mRNA Drug in 2022
  3.5.3 Global Concentration Ratios (CR8) for mRNA Drug in 2022
3.6 mRNA Drug Market: Overall Company Footprint Analysis
  3.6.1 mRNA Drug Market: Region Footprint
  3.6.2 mRNA Drug Market: Company Product Type Footprint
  3.6.3 mRNA Drug Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: mRNA Drug Production Value Comparison
  4.1.1 United States VS China: mRNA Drug Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: mRNA Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: mRNA Drug Production Comparison
  4.2.1 United States VS China: mRNA Drug Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: mRNA Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: mRNA Drug Consumption Comparison
  4.3.1 United States VS China: mRNA Drug Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: mRNA Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based mRNA Drug Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based mRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers mRNA Drug Production Value (2018-2023)
  4.4.3 United States Based Manufacturers mRNA Drug Production (2018-2023)
4.5 China Based mRNA Drug Manufacturers and Market Share
  4.5.1 China Based mRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers mRNA Drug Production Value (2018-2023)
  4.5.3 China Based Manufacturers mRNA Drug Production (2018-2023)
4.6 Rest of World Based mRNA Drug Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based mRNA Drug Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers mRNA Drug Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers mRNA Drug Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World mRNA Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Preventive Vaccines
  5.2.2 Therapeutic Vaccine
  5.2.3 Therapeutic Drugs
5.3 Market Segment by Type
  5.3.1 World mRNA Drug Production by Type (2018-2029)
  5.3.2 World mRNA Drug Production Value by Type (2018-2029)
  5.3.3 World mRNA Drug Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World mRNA Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
6.3 Market Segment by Application
  6.3.1 World mRNA Drug Production by Application (2018-2029)
  6.3.2 World mRNA Drug Production Value by Application (2018-2029)
  6.3.3 World mRNA Drug Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Moderna
  7.1.1 Moderna Details
  7.1.2 Moderna Major Business
  7.1.3 Moderna mRNA Drug Product and Services
  7.1.4 Moderna mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Moderna Recent Developments/Updates
  7.1.6 Moderna Competitive Strengths & Weaknesses
7.2 Pfizer
  7.2.1 Pfizer Details
  7.2.2 Pfizer Major Business
  7.2.3 Pfizer mRNA Drug Product and Services
  7.2.4 Pfizer mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Pfizer Recent Developments/Updates
  7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Zydus Cadila
  7.3.1 Zydus Cadila Details
  7.3.2 Zydus Cadila Major Business
  7.3.3 Zydus Cadila mRNA Drug Product and Services
  7.3.4 Zydus Cadila mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Zydus Cadila Recent Developments/Updates
  7.3.6 Zydus Cadila Competitive Strengths & Weaknesses
7.4 Fosun Pharma
  7.4.1 Fosun Pharma Details
  7.4.2 Fosun Pharma Major Business
  7.4.3 Fosun Pharma mRNA Drug Product and Services
  7.4.4 Fosun Pharma mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Fosun Pharma Recent Developments/Updates
  7.4.6 Fosun Pharma Competitive Strengths & Weaknesses
7.5 CureVAC
  7.5.1 CureVAC Details
  7.5.2 CureVAC Major Business
  7.5.3 CureVAC mRNA Drug Product and Services
  7.5.4 CureVAC mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 CureVAC Recent Developments/Updates
  7.5.6 CureVAC Competitive Strengths & Weaknesses
7.6 Sri Lankan Microorganisms
  7.6.1 Sri Lankan Microorganisms Details
  7.6.2 Sri Lankan Microorganisms Major Business
  7.6.3 Sri Lankan Microorganisms mRNA Drug Product and Services
  7.6.4 Sri Lankan Microorganisms mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Sri Lankan Microorganisms Recent Developments/Updates
  7.6.6 Sri Lankan Microorganisms Competitive Strengths & Weaknesses
7.7 BioNtech
  7.7.1 BioNtech Details
  7.7.2 BioNtech Major Business
  7.7.3 BioNtech mRNA Drug Product and Services
  7.7.4 BioNtech mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 BioNtech Recent Developments/Updates
  7.7.6 BioNtech Competitive Strengths & Weaknesses
7.8 AstraZeneca
  7.8.1 AstraZeneca Details
  7.8.2 AstraZeneca Major Business
  7.8.3 AstraZeneca mRNA Drug Product and Services
  7.8.4 AstraZeneca mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 AstraZeneca Recent Developments/Updates
  7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Janssen
  7.9.1 Janssen Details
  7.9.2 Janssen Major Business
  7.9.3 Janssen mRNA Drug Product and Services
  7.9.4 Janssen mRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Janssen Recent Developments/Updates
  7.9.6 Janssen Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 mRNA Drug Industry Chain
8.2 mRNA Drug Upstream Analysis
  8.2.1 mRNA Drug Core Raw Materials
  8.2.2 Main Manufacturers of mRNA Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 mRNA Drug Production Mode
8.6 mRNA Drug Procurement Model
8.7 mRNA Drug Industry Sales Model and Sales Channels
  8.7.1 mRNA Drug Sales Model
  8.7.2 mRNA Drug Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World mRNA Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World mRNA Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World mRNA Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World mRNA Drug Production Value Market Share by Region (2018-2023)
Table 5. World mRNA Drug Production Value Market Share by Region (2024-2029)
Table 6. World mRNA Drug Production by Region (2018-2023) & (K Units)
Table 7. World mRNA Drug Production by Region (2024-2029) & (K Units)
Table 8. World mRNA Drug Production Market Share by Region (2018-2023)
Table 9. World mRNA Drug Production Market Share by Region (2024-2029)
Table 10. World mRNA Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World mRNA Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. mRNA Drug Major Market Trends
Table 13. World mRNA Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World mRNA Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World mRNA Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World mRNA Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Drug Producers in 2022
Table 18. World mRNA Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key mRNA Drug Producers in 2022
Table 20. World mRNA Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global mRNA Drug Company Evaluation Quadrant
Table 22. World mRNA Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and mRNA Drug Production Site of Key Manufacturer
Table 24. mRNA Drug Market: Company Product Type Footprint
Table 25. mRNA Drug Market: Company Product Application Footprint
Table 26. mRNA Drug Competitive Factors
Table 27. mRNA Drug New Entrant and Capacity Expansion Plans
Table 28. mRNA Drug Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China mRNA Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China mRNA Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based mRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers mRNA Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers mRNA Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers mRNA Drug Production Market Share (2018-2023)
Table 37. China Based mRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers mRNA Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers mRNA Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers mRNA Drug Production Market Share (2018-2023)
Table 42. Rest of World Based mRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers mRNA Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers mRNA Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers mRNA Drug Production Market Share (2018-2023)
Table 47. World mRNA Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World mRNA Drug Production by Type (2018-2023) & (K Units)
Table 49. World mRNA Drug Production by Type (2024-2029) & (K Units)
Table 50. World mRNA Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World mRNA Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World mRNA Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World mRNA Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World mRNA Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World mRNA Drug Production by Application (2018-2023) & (K Units)
Table 56. World mRNA Drug Production by Application (2024-2029) & (K Units)
Table 57. World mRNA Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World mRNA Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World mRNA Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World mRNA Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Moderna Basic Information, Manufacturing Base and Competitors
Table 62. Moderna Major Business
Table 63. Moderna mRNA Drug Product and Services
Table 64. Moderna mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Moderna Recent Developments/Updates
Table 66. Moderna Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer mRNA Drug Product and Services
Table 70. Pfizer mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 74. Zydus Cadila Major Business
Table 75. Zydus Cadila mRNA Drug Product and Services
Table 76. Zydus Cadila mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Zydus Cadila Recent Developments/Updates
Table 78. Zydus Cadila Competitive Strengths & Weaknesses
Table 79. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Fosun Pharma Major Business
Table 81. Fosun Pharma mRNA Drug Product and Services
Table 82. Fosun Pharma mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Fosun Pharma Recent Developments/Updates
Table 84. Fosun Pharma Competitive Strengths & Weaknesses
Table 85. CureVAC Basic Information, Manufacturing Base and Competitors
Table 86. CureVAC Major Business
Table 87. CureVAC mRNA Drug Product and Services
Table 88. CureVAC mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. CureVAC Recent Developments/Updates
Table 90. CureVAC Competitive Strengths & Weaknesses
Table 91. Sri Lankan Microorganisms Basic Information, Manufacturing Base and Competitors
Table 92. Sri Lankan Microorganisms Major Business
Table 93. Sri Lankan Microorganisms mRNA Drug Product and Services
Table 94. Sri Lankan Microorganisms mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sri Lankan Microorganisms Recent Developments/Updates
Table 96. Sri Lankan Microorganisms Competitive Strengths & Weaknesses
Table 97. BioNtech Basic Information, Manufacturing Base and Competitors
Table 98. BioNtech Major Business
Table 99. BioNtech mRNA Drug Product and Services
Table 100. BioNtech mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. BioNtech Recent Developments/Updates
Table 102. BioNtech Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca mRNA Drug Product and Services
Table 106. AstraZeneca mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. Janssen Basic Information, Manufacturing Base and Competitors
Table 109. Janssen Major Business
Table 110. Janssen mRNA Drug Product and Services
Table 111. Janssen mRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of mRNA Drug Upstream (Raw Materials)
Table 113. mRNA Drug Typical Customers
Table 114. mRNA Drug Typical Distributors

LIST OF FIGURES

Figure 1. mRNA Drug Picture
Figure 2. World mRNA Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World mRNA Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World mRNA Drug Production (2018-2029) & (K Units)
Figure 5. World mRNA Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World mRNA Drug Production Value Market Share by Region (2018-2029)
Figure 7. World mRNA Drug Production Market Share by Region (2018-2029)
Figure 8. North America mRNA Drug Production (2018-2029) & (K Units)
Figure 9. Europe mRNA Drug Production (2018-2029) & (K Units)
Figure 10. China mRNA Drug Production (2018-2029) & (K Units)
Figure 11. Japan mRNA Drug Production (2018-2029) & (K Units)
Figure 12. mRNA Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World mRNA Drug Consumption (2018-2029) & (K Units)
Figure 15. World mRNA Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States mRNA Drug Consumption (2018-2029) & (K Units)
Figure 17. China mRNA Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe mRNA Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan mRNA Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea mRNA Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN mRNA Drug Consumption (2018-2029) & (K Units)
Figure 22. India mRNA Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of mRNA Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Drug Markets in 2022
Figure 26. United States VS China: mRNA Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: mRNA Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: mRNA Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers mRNA Drug Production Market Share 2022
Figure 30. China Based Manufacturers mRNA Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers mRNA Drug Production Market Share 2022
Figure 32. World mRNA Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World mRNA Drug Production Value Market Share by Type in 2022
Figure 34. Preventive Vaccines
Figure 35. Therapeutic Vaccine
Figure 36. Therapeutic Drugs
Figure 37. World mRNA Drug Production Market Share by Type (2018-2029)
Figure 38. World mRNA Drug Production Value Market Share by Type (2018-2029)
Figure 39. World mRNA Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World mRNA Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World mRNA Drug Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. World mRNA Drug Production Market Share by Application (2018-2029)
Figure 45. World mRNA Drug Production Value Market Share by Application (2018-2029)
Figure 46. World mRNA Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. mRNA Drug Industry Chain
Figure 48. mRNA Drug Procurement Model
Figure 49. mRNA Drug Sales Model
Figure 50. mRNA Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source


More Publications